These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8676200)

  • 21. Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues.
    Kinsella TJ; Kunugi KA; Vielhuber KA; Potter DM; Fitzsimmons ME; Collins JM
    Clin Cancer Res; 1998 Jan; 4(1):99-109. PubMed ID: 9516958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical animal studies with radioiododeoxyuridine.
    Kassis AI; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
    Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
    Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer.
    Mariani G; Cei A; Collecchi P; Baranowska-Kortylewicz J; Van den Abbeele AD; Di Luca L; Di Stefano R; Viacava P; Ferdeghini EM; Di Sacco S
    J Nucl Med; 1993 Jul; 34(7):1175-83. PubMed ID: 8315499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategies.
    Schneiderman MH; Schneiderman GS
    J Nucl Med; 1996 Apr; 37(4 Suppl):6S-9S. PubMed ID: 8676203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
    Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
    J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine.
    Blasberg RG; Roelcke U; Weinreich R; Beattie B; von Ammon K; Yonekawa Y; Landolt H; Guenther I; Crompton NE; Vontobel P; Missimer J; Maguire RP; Koziorowski J; Knust EJ; Finn RD; Leenders KL
    Cancer Res; 2000 Feb; 60(3):624-35. PubMed ID: 10676646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
    J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting tumors with iodine-123 labeled deoxyuridine: distribution and DNA binding.
    Thakur ML; Li J; Kim SM; Zhang JJ; Andrews D
    Cancer Detect Prev; 1999; 23(1):72-7. PubMed ID: 9892993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential for tumor therapy with iodine-125 labeled immunoglobulins.
    Adelstein SJ; Kassis AI; Baranowska-Kortylewicz J; van den Abbeele AD; Mariani G; Ito S
    Int J Rad Appl Instrum B; 1991; 18(1):43-4. PubMed ID: 2010304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of DNA-targeted ionizing radiation produced by 5-[125I]iodo-2'-deoxyuridine on global gene expression in primary human cells.
    Sokolov MV; Neumann RD; Panyutin IG
    BMC Genomics; 2007 Jun; 8():192. PubMed ID: 17594496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
    Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
    Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
    Schulz CA; Mehta MP; Badie B; McGinn CJ; Robins HI; Hayes L; Chappell R; Volkman J; Binger K; Arzoomanian R; Simon K; Alberti D; Feierabend C; Tutsch KD; Kunugi KA; Wilding G; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1107-15. PubMed ID: 15234045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma.
    Divgi CR; Scott AM; Gulec S; Broussard EK; Levy N; Young C; Capitelli P; Daghighian F; Williams JM; Finn RD
    Clin Cancer Res; 1995 Dec; 1(12):1503-10. PubMed ID: 9815950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
    Reza MS; Whateley TL
    J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma.
    Madsen MT; Park CH; Thakur ML
    J Nucl Med; 1988 Jun; 29(6):1038-44. PubMed ID: 2836572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases.
    Sahu SK; Wen PY; Foulon CF; Nagel JS; Black PM; Adelstein SJ; Kassis AI
    J Nucl Med; 1997 Mar; 38(3):386-90. PubMed ID: 9074525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
    Humm JL; Bagshawe KD; Sharma SK; Boxer G
    Br J Radiol; 1991 Jan; 64(757):45-9. PubMed ID: 1998837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iododeoxyuridine uptake and retention as a measure of tumor growth.
    Tjuvajev J; Muraki A; Ginos J; Berk J; Koutcher J; Ballon D; Beattie B; Finn R; Dahighian F; Blasberg R
    J Nucl Med; 1993 Jul; 34(7):1152-62. PubMed ID: 8315494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.
    Divgi CR; Scott AM; Dantis L; Capitelli P; Siler K; Hilton S; Finn RD; Kemeny N; Kelsen D; Kostakoglu L
    J Nucl Med; 1995 Apr; 36(4):586-92. PubMed ID: 7699446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.